PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Propoxyphene Hydrochloride And Acetaminophen, and when can generic versions of Propoxyphene Hydrochloride And Acetaminophen launch?
Propoxyphene Hydrochloride And Acetaminophen is a drug marketed by Mylan, Sandoz, Vintage Pharms, and Watson Labs. and is included in five NDAs.
The generic ingredient in PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN is acetaminophen; propoxyphene hydrochloride. There are sixty-six drug master file entries for this compound. Additional details are available on the acetaminophen; propoxyphene hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN?
- What are the global sales for PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN?
- What is Average Wholesale Price for PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN?
Summary for PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 11 |
Clinical Trials: | 5 |
Patent Applications: | 294 |
DailyMed Link: | PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN at DailyMed |
Recent Clinical Trials for PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mansoura University | Phase 1/Phase 2 |
Federal University of São Paulo | Phase 4 |
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
See all PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN clinical trials